The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 1, 2002, Pages 152-160

  Pitteloud, Nelly ^a   Hayes, Frances J ^a   Boepple, Paul A ^a   Decruz, Suzzunne ^a   Seminara, Stephanie B ^a   MacLaughlin, David T ^a   Crowley Jr , William F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; GONADORELIN; GONADOTROPIN; INHIBIN B; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR;

ADULT; ANOSMIA; ARTICLE; CONTROLLED STUDY; CRYPTORCHISM; DISEASE CLASSIFICATION; DISEASE SEVERITY; GENE MUTATION; HISTOLOGY; HORMONE DEFICIENCY; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; IDIOPATHIC DISEASE; INCIDENCE; KALLMANN SYNDROME; LUTEINIZING HORMONE RELEASE; MAJOR CLINICAL STUDY; MALE; MATURATION; MICROPENIS; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PUBERTY; TESTIS DEVELOPMENT; TESTIS SIZE;

MICROPHALLUS;

EID: 0036149989     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.1.8131     Document Type: Article

References (62)

1. Serum luteinizing hormone concentrations increase 100-fold in females from 7 years to adulthood, as measured by time-resolved immunofluorometric assay
2. Patterns of pulsatile luteinizing hormone secretion before and during the onset of puberty in boys: A study using an immunoradiometric assay
3. Human puberty. Simultaneous augmented secretion of luteinizing hormone and testosterone during sleep
4. Targeted disruption of the Ins13 gene causes bilateral cryptorchidism
5. Prevalence and natural history of cryptorchidism
6. A biphasic model for the hormonal control of testicular descent
7. Maldescendus testis
8. Further observations on the blood-testis barrier in monkeys
9. Postnatal development of the Sertoli cell barrier, tubular lumen, and cytoskeleton of Sertoli and myoid cells in the rat, and their relationship to tubular fluid secretion and flow
10. Is infancy a quiescent period of testicular development? Histological, morphometric, and functional study of the seminiferous tubules of the cebus monkey from birth to the end of puberty
11. Proliferation of Sertoli cells during development of the human testis assessed by stereological methods
12. Hypogonadotropic hypogonadism: Hormonal responses to low dose pulsatile administration of gonadotropin-releasing hormone
13. Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): Pathophysiological and genetic considerations
14. The genetic aspects of primary eunuchoidism
15. Clinical and laboratory heterogeneity in idiopathic hypogonadotropic hypogonadism
16. The spectrum of abnormal patterns of gonadotropin-releasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism: Clinical and laboratory correlations
17. Adult-onset idiopathic hypogonadotropic hypogonadism-a treatable form of male infertility
18. The syndrome of anosmia with hypogonadotropic hypogonadism: A genetic study of 18 new families and a review
19. The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human
20. Unilateral renal aplasia in X-linked Kallmann's syndrome
21. The neuroradiology of Kallmann's syndrome: A genotypic and phenotypic analysis
22. Studies of the pituitary-Leydig cell axis in young men with hypogodotropic hypogonadism and hyposmia: Comparison with normal men, prepubertal boys, and hypopituitary patients
23. Isolated gonadotropin deficiency in boys: Clinical characteristics and growth
24. Hypogonadotropic disorders in men and women: Diagnosis and therapy with pulsatile gonadotropin-releasing hormone
25. A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules
26. Brief report: Intragenic deletion of the KALIG-1 gene in Kallmann's syndrome
27. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor
28. Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism
29. Complete hypogonadotropic hypogonadism associated with a novel inactivating mutation of the gonadotropin-releasing hormone receptor
30. Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration
31. The same molecular defects of the gonadotropin-releasing hormone receptor determine a variable degree of hypogonadism in affected kindred
32. Successful use of pulsatile gonadotropin-releasing hormone (GnRH) for ovulation induction and pregnancy in a patient with GnRH receptor mutations
33. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita
34. Hypogonadotropic hypogonadism in a female caused by an X-linked recessive mutation in the DAX1 gene
35. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: Evidence that DAX-1 mutations lead to combined hypothalmic and pituitary defects in gonadotropin production
36. Measurement of dimeric inhibin B throughout the human menstrual cycle
37. Anti-Mullerian hormone is a functional marker of foetal Sertoli cells
38. Congenital hypogonadotropic hypogonadism and micropenis: Effect of testosterone treatment on adult penile size why sex reversal is not indicated
39. Genetic heterogeneity evidenced by low incidence of KAL-1 gene mutations in sporadic cases of gonadotropin-releasing hormone deficiency
40. The importance of autosomal genes in kallmann syndrome: Genotype-phenotype correlations and neuroendocrine characteristics
41. Free α-subunit is superior to luteinizing hormone as a marker of gonadotropin-releasing hormone despite desensitization at fast pulse frequencies
42. The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic men
43. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion
44. Mullerian inhibiting substance in humans: Normal levels from infancy to adulthood
45. A syndrome of eunuchoidism with spermatogenesis, normal urinary FSH and low or normal ICSH: "Fertile eunuchs"
46. Inhibin B secretion in males with gonadotropin-releasing hormone (GnRH) deficiency before and during long-term GnRH replacement: Relationship to spontaneous puberty, testicular volume, and prior treatment-a clinical research center study
47. Inhibin B in males with gonadotropin-releasing hormone (GnRH) deficiency: Changes in serum concentration after short term physiologic GnRH replacement-a clinical research center study
48. Antimullerian hormone in patients with hypogonadotropic hypogonadism
49. Fertile eunuch syndrome versus classic hypogonadotrophic hypogonadism
50. Studies of the pituitary-Leydig cell axis in young men with hypogonadotropic hypogonadism and hyposmia: Comparison with normal men, prepuberal boys, and hypopituitary patients
51. Prenatal diagnosis and investigation of a fetus with chondrodysplasia punctata, ichthyosis, and Kallmann syndrome due to an Xp deletion
52. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules
53. X chromosome-linked Kallmann syndrome: Stop mutations validate the candidate gene
54. The fertile eunuch variant of idiopathic hypogonadotropic hypogonadism: Spontaneous reversal associated with a homozygous mutation in the gonadotropin-releasing hormone receptor
55. Long-term administration of gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism: A model for studies of the hormone's physiologic effects
56. The undescended testis. Theory and management
57. Testicular feminization: A model for testicular descent in mice and men
58. Different roles of prepubertal and postpubertal germ cells and Sertoli cells in the regulation of serum inhibin B levels
59. Regulation of biologically active dimeric inhibin A and B from infancy to adulthood in the male
60. Serum inhibin B in healthy pubertal and adolescent boys: Relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels
61. Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction
62. Assessment of testicular cytology by fine needle aspiration as a diagnostic parameter in the evaluation of the azoospermic subject